In luminal breast cancer cells, GATA3 is known to functionally interact with the TFs FOXA1 and estrogen receptor-α [28, 58], leading to the potential for GATA3 mutations to alter the transcriptional network of these factors. Here, ESR1 is linked to breast carcinoma.